Tirzepatide for PCOS: separating real benefits from hype

What did @lizparry actually say?

In short: she's three months into using compounded tirzepatide sourced from unregulated peptide vendors, not a licensed pharmacy, and she's actively coaching her followers to do the same using Reddit-sourced purity testing websites.

She names two vendors, "Tides" and "Amino Peptides," rates them based on a third-party testing site she found on Reddit, and admits she's "pretty much winging it" and "not an expert." That last part is at least honest. But recommending vendor selection based on crowd-sourced Reddit ratings for research-grade peptides to 103,000 viewers is worth unpacking carefully.

She also says she's using tirzepatide for PCOS and "endometriosis inflammation," neither of which are FDA-approved indications for tirzepatide. That doesn't automatically make it wrong, but it matters for context.

Does the science back any of this up?

The evidence for GLP-1 agonists in PCOS is genuinely interesting, but it's early and the tirzepatide data specifically is thin. The endometriosis claim has almost no direct clinical support yet.

For PCOS, a 2023 trial by Fruzzetti et al. in the Journal of Clinical Endocrinology and Metabolism found GLP-1 receptor agonists improved insulin resistance and androgen levels in women with PCOS, but most data involves semaglutide or liraglutide, not tirzepatide. A 2024 review by Moiz et al. in Frontiers in Endocrinology acknowledged tirzepatide's dual GIP/GLP-1 mechanism may have additional metabolic benefits in PCOS, but called the evidence base "preliminary."

For endometriosis, a 2023 study by Herington et al. in Biology of Reproduction showed GLP-1 receptor agonists reduced inflammatory markers in an endometriosis mouse model, which is interesting but a very long way from human clinical evidence. Describing tirzepatide as treating "endometriosis inflammation" as if it's established is a stretch.

What did they get wrong, and what did they get right?

Wrong: Sourcing tirzepatide from research peptide vendors is not the same as obtaining compounded tirzepatide from an FDA-registered 503A or 503B pharmacy. This distinction is not semantic. Research peptides are sold explicitly "not for human use" and operate outside pharmaceutical quality controls. Purity certificates from Reddit-vetted websites do not substitute for USP-compliant compounding standards.

Right: She does correctly acknowledge she's not an expert, she's comparing vendors rather than just endorsing one blindly, and she's noting quality variation between sources. That's more self-awareness than most peptide TikTok content. The concern about "legitness" she raises is real. Counterfeiting and contamination in the research peptide market are documented problems.

Wrong: Framing the Reddit testing site as a reliable quality-assurance system is misleading. Third-party testing services that accept user-submitted samples can only test what's submitted, and cannot verify batch consistency, sterility, or what you actually received.

What should you actually know?

If you're considering GLP-1 or GIP/GLP-1 therapy for PCOS or related conditions, the access pathway matters enormously. Here's what the regulatory picture actually looks like.

• Tirzepatide (Zepbound, Mounjaro) is FDA-approved for obesity and type 2 diabetes, not PCOS or endometriosis. Off-label prescribing by a licensed physician is legal and common, but it requires actual medical oversight.
• Compounded tirzepatide from a licensed 503A pharmacy with a valid prescription is legally distinct from research-grade peptides sold by vendors like the ones named in this video. The FDA has issued multiple warning letters about illegally marketed tirzepatide products.
• Research peptide vendors operate in a gray-to-black legal area for human use. The FDA's position is clear: products labeled "not for human use" that are sold knowing they will be used by humans can be subject to enforcement action.
• Self-dosing injectable peptides without medical supervision carries real risks: incorrect reconstitution, dosing errors, contamination, and no monitoring for side effects like pancreatitis or thyroid changes that require clinical follow-up.
• The informal quality-testing community she references does real work, but a Reddit-aggregated grade is not a substitute for a Certificate of Analysis from an accredited lab tied to the specific vial you inject.

The bottom line

@lizparry is likable, transparent about her uncertainty, and engaging with a real community question about access. But "I did a lot of research on Reddit" is not a safety protocol for injectable peptides, and 103,000 viewers deserve to know the difference between a research chemical and a regulated pharmaceutical. The science on GLP-1 agents for PCOS is promising but not settled. The vendor-sourcing approach she describes bypasses every layer of oversight that exists to catch contaminated or mislabeled products before they end up in someone's body.